Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Houston

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Journal of the American Heart Association|April 3, 2017
Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular DiseaseNabanita Kundu, Cleyton C Domingues, Cyril Chou, et al.
Prehospital Emergency Care|April 25, 2015
Probability of Return of Spontaneous Circulation as a Function of Timing of Vasopressor Administration in Out-of-Hospital Cardiac ArrestMichael W Hubble, Christopher Johnson, Jamie Blackwelder, et al.
Cardiovascular Diabetology|May 5, 2018
The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trialFiona J Dore, Cleyton C Domingues, Neeki Ahmadi, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Journal of the American Heart Association|April 3, 2017
Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular DiseaseNabanita Kundu, Cleyton C Domingues, Cyril Chou, et al.
Prehospital Emergency Care|April 25, 2015
Probability of Return of Spontaneous Circulation as a Function of Timing of Vasopressor Administration in Out-of-Hospital Cardiac ArrestMichael W Hubble, Christopher Johnson, Jamie Blackwelder, et al.
Cardiovascular Diabetology|May 5, 2018
The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trialFiona J Dore, Cleyton C Domingues, Neeki Ahmadi, et al.
Pageof 2